Tag: adhdtreatment
ADHD Medication Could Be a Lifesaver, New Study Suggests
In a significant observational study conducted in Sweden, researchers have uncovered a potentially life-saving benefit of attention-deficit/hyperactivity disorder (ADHD) medication. The study, involving 148,578 individuals diagnosed with ADHD, reveals that the initiation of ADHD medication is associated with a reduced risk of death, especially from unnatural causes such as accidents and suicides. This comprehensive analysis,…
New ADHD Treatments Herald Comorbid Anxiety & Depression
In the realm of Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, four promising pipeline agents are currently under late-stage development across the seven major markets (7MM), including the United States, Japan, Germany, the United Kingdom, France, Italy, and Spain. These agents are Otsuka’s Centanafadine SR, Axsome Therapeutics’s Solriamfetol, Neurocentria’s NRCT-101SR (L-Threonate magnesium salt), and Cingulate’s CTx-1301 (dexmethylphenidate). Notably,…
Stimulant Use in ADHD with ASD and Psychosis: A Case Study
Published on 31/01/2024 in Cureus The case study paper explores the association between autism spectrum disorder (ASD) and common mental health disorders, focusing on the prevalence of attention deficit hyperactivity disorder (ADHD) in individuals with ASD and the use of stimulant medications as a treatment. The paper presents a case study of a 13-year-old male…
Viloxazine More Effective Than Atomoxetine
Published on 10/07/2023 in CNS Drugs (Springer) The study was conducted retrospectively with data obtained for clinical purposes and received no specific grant from funding agencies. The authors disclosed no conflicts of interest and provided substantial contributions to the conception and design of the work. References: Price, Maxwell Zachary, and Richard L. Price. “Extended-Release Viloxazine…
ADHD Stimulant Treatment Cuts Suicide Risk!
Published in BJPsych Open(Cambridge) on 22/01/2024 Suicide and the association of mental illness, particularly attention-deficit hyperactivity disorder (ADHD), with increased risk of suicide attempts and mortality is a significant public health concern in the USA. Traditional theories have focused on depression and isolation as primary risk factors for suicide, but there is a growing body…
ADHD Medication Discontinuation: An In-depth Analysis
On November 23, 2023, Lancet Psychiatry published a meta-analysis delving into the critical issue of ADHD medication discontinuation and persistence across diverse age groups and countries. The study aimed to unravel the patterns, reasons, and implications of ADHD medication cessation, offering valuable insights for enhancing treatment strategies. With an extensive dataset encompassing 1,229,972 individuals initiating…
